1. LBA53IMpower130: Progression-free survival (PFS) and safety analysis from a randomised phase III study of carboplatin + nab-paclitaxel (CnP) with or without atezolizumab (atezo) as first-line (1L) therapy in advanced non-squamous NSCLC. (23rd October 2018) Authors: Cappuzzo, F; McCleod, M; Hussein, M; Morabito, A; Rittmeyer, A; Conter, H J; Kopp, H-G; Daniel, D; McCune, S; Mekhail, T; Zer, A; Reinmuth, N; Sadiq, A; Archer, V; Ochi Lohmann, T; Wang, L; Kowanetz, M; Lin, W; Sandler, A; West, H Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 529POsimertinib for patients with EGFR-mutant advanced NSCLC and asymptomatic brain metastases: An open-label, two-arm, phase II study. (24th November 2019) Authors: Gillis, R; Peled, N; Goldshtien, I; Rotem, O; Rozenblum, A B; Nechushtan, H; Chen, L; Dudnik, E; Zer, A; Yust-Katz, S; Shelef, I; Roisman, L C; Inbar, E Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 404OA phase II single arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated Classical Kaposi Sarcoma (CKS). (24th November 2019) Authors: Zer, A; Icht, O; Jacobi, O; Fenig, E; Shamai, S; Merimsky, O; Shapira, R; Bernstine, H; Weitzen, R; Vornikova, O; Ben-Ami, E; Bar-Sela, G; Stemmer, S M; Lotem, M Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1403PEfficacy of immune check-point inhibitors (ICPi) in large cell neuroendocrine tumours of lung (LCNET). (1st October 2019) Authors: Sherman, S; Rotem, O; Zer, A; Shochat, T; Dudnik, E Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗